The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.1362
Abstract: The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium (BC) is a public–private partnership that aims to facilitate drug development with biomarkers across a range of therapeutic areas. The BC is organized to… read more here.
Keywords: biomarker; biomarkers consortium; institutes health; foundation national ... See more keywords
Association of knee OA structural phenotypes to risk for progression: a secondary analysis from the Foundation for National Institutes of Health Osteoarthritis Biomarkers study (FNIH).
Sign Up to like & getrecommendations! Published in 2020 at "Osteoarthritis and cartilage"
DOI: 10.1016/j.joca.2020.05.008
Abstract: PURPOSE Aim was to stratify the knee MRIs of the Foundation for National Institutes of Health Osteoarthritis Biomarkers Consortium (FNIH) cohort into distinct structural phenotypes based on semiquantitative assessment and to determine risk for pain… read more here.
Keywords: phenotype; risk; institutes health; foundation national ... See more keywords